Results 191 to 200 of about 35,031,112 (253)
Correction to: Neighborhood geographic disparities in colorectal, prostate, breast, and lung cancer risk in Alabama. [PDF]
Buchalter RB +7 more
europepmc +1 more source
Efficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
ABSTRACT Background Neuromyelitis optica spectrum disorders (NMOSD) usually occur with acute refractory optic neuritis (ON). However, there is a lack of efficacious treatments to improve recovery. Since fampridine has been found to improve the prognosis of multiple sclerosis (MS) and MS‐related ON, it is necessary to explore the efficacy of fampridine ...
Hongxuan Wang +9 more
wiley +1 more source
Correction to: Comprehensive Genomic Analysis in Hereditary Adrenal and Extra- Adrenal Paragangliomas. [PDF]
Purnaghshband H +13 more
europepmc +1 more source
The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta +11 more
wiley +1 more source
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
ABSTRACT Objective Inherited ataxias are clinically diverse neurodegenerative diseases, complicating the choice of outcome measures for trials. In spinocerebellar ataxia (SCA), regulatory concerns about the Scale for the Assessment and Rating of Ataxia (SARA) caused a shift toward functional SARA (f‐SARA), contributing to pivotal trial failure.
Christian Rummey +52 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Medicinal Chemistry, 2021
Selection of R-groups (substituents, functional groups) is of critical importance for the generation of analogues during hit-to-lead and lead optimization. In the practice of medicinal chemistry, R-group selection is mostly driven by chemical experience and intuition taking synthetic criteria into account.
Kosuke Takeuchi +2 more
openaire +2 more sources
Selection of R-groups (substituents, functional groups) is of critical importance for the generation of analogues during hit-to-lead and lead optimization. In the practice of medicinal chemistry, R-group selection is mostly driven by chemical experience and intuition taking synthetic criteria into account.
Kosuke Takeuchi +2 more
openaire +2 more sources
Journal of Clinical Oncology, 2017
6506 Background: R policies for NGS testing vary widely among private and public insurers. While drug costs are the greatest challenge in personalized or precision medicine, cost and R are substantial barriers to genomic profiling with NGS. We examined variation in coverage and R for a cohort of cancer patients (pts) treated at a tertiary oncology ...
Thomas D. Brown +19 more
openaire +1 more source
6506 Background: R policies for NGS testing vary widely among private and public insurers. While drug costs are the greatest challenge in personalized or precision medicine, cost and R are substantial barriers to genomic profiling with NGS. We examined variation in coverage and R for a cohort of cancer patients (pts) treated at a tertiary oncology ...
Thomas D. Brown +19 more
openaire +1 more source
Clinical Pharmacology & Therapeutics, 2017
In the latter part of the 20th century, drug development in cardiovascular diseases (CVDs) was a paragon of “modern” therapeutics, bringing about a substantial number of effective, well‐tolerated agents targeting some of the most prevalent diseases of the Western world.
openaire +2 more sources
In the latter part of the 20th century, drug development in cardiovascular diseases (CVDs) was a paragon of “modern” therapeutics, bringing about a substantial number of effective, well‐tolerated agents targeting some of the most prevalent diseases of the Western world.
openaire +2 more sources

